Evidence map›Paper›PMID 33608774›Full record

ArticleMikrochimica acta2021

Voltammetric measurement of entacapone in the presence of other medicines against Parkinson's disease by a screen-printed electrode modified with sulfur-tin oxide nanoparticles.

Ebrahim Naghian, Faezeh Shahdost-Fard, Mostafa Najafi, Mohammad Reza Manafi, Leila Torkian, Mehdi Rahimi-Nasrabadi

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ebrahim NaghianDepartment of Chemistry, South Tehran Branch Islamic Azad University, Tehran, Iran.
Faezeh Shahdost-FardDepartment of Chemistry, Ilam University, Ilam, Iran.
Mostafa NajafiDepartment of Chemistry, Faculty of Science, Imam Hossein University, Tehran, Iran. mnajafi@ihu.ac.ir.
Mohammad Reza ManafiDepartment of Chemistry, South Tehran Branch Islamic Azad University, Tehran, Iran.
Leila TorkianDepartment of Chemistry, South Tehran Branch Islamic Azad University, Tehran, Iran.
Mehdi Rahimi-NasrabadiChemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. rahimi@bmsu.ac.ir.ORCID 0000-0003-4926-2696
Baqiyatallah University of Medical Sciences · IRIslamic Azad University South Tehran Branch · IRIlam University · IRImam Hossein University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A screen-printed electrode (SPE) is described modified with sulfur-tin oxide nanoparticles (S@SnO

Indexed as

Antiparkinson AgentsCatecholsElectrochemical TechniquesElectrodesHumansLimit of DetectionMetal NanoparticlesNitrilesOxidation-ReductionSulfurTabletsTin CompoundsAntiparkinson AgentsCatecholsentacaponeNitrilesstannic oxideSulfurTabletsTin CompoundsEntacaponeParkinson diseaseScreen-printed electrodeSulfur-tin oxide nanoparticleVoltammetry

Identifiers

PMID33608774
OpenAlexW3131874136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.